Nasal decolonization is recommended by the WHO and CDC to reduce hospital acquired infections (HAIs), [1] which have been exacerbated by COVID. [2] HAIs in U.S. hospitals cause up to… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, will report financial results for the fiscal… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announces that Eric A. Adams, CEO… Read More
EP-104IAR Phase 1 study results published in Osteoarthritis and Cartilage Open Company continues to expand its patent estate for EP-104IAR with patent grant in Israel VICTORIA, BC – Eupraxia Pharmaceuticals… Read More
VANCOUVER, BC – Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg… Read More
